Change in HbA(1c) Across the Baseline HbA(1c) Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents

INTRODUCTION: This exploratory post hoc analysis investigated the relative changes in glycated haemoglobin (HbA(1c)) in patients with type 2 diabetes mellitus (T2DM) treated with dulaglutide versus active comparators across a continuous range of baseline HbA(1c) values using data from three phase II...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Ther
Hlavní autoři: Gentilella, Raffaella, Romera, Irene, Nicolay, Claudia, Buzzetti, Raffaella, Vázquez, Luis Alberto, Sesti, Giorgio
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Healthcare 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6531505/
https://ncbi.nlm.nih.gov/pubmed/31055780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-0625-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky